Profile
NIVF UNH ANTM CVS CI ELV
Company Name NewGenIvf Group Limited UnitedHealth Group Incorporated Elevance Health Inc. CVS Health Corporation Cigna Corporation Elevance Health Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Healthcare Plans Medical - Healthcare Plans Medical - Healthcare Plans Medical - Healthcare Plans Medical - Healthcare Plans Medical - Healthcare Plans
Market Cap $24.38K $247.49B $114.59B $96.10B $76.88B $71.87B
Employees 0.08K 400.00K 98.20K 219.00K 71.30K 104.20K
CEO Wing Fung Siu Stephen J. Hemsley Gail Boudreaux J. David Joyner David Michael Cordani Gail Koziara Boudreaux
Ratings
NIVF UNH ANTM CVS CI ELV
Quant Rating Score 5 3 5 3 2 4
Quant Rating Strong Buy Neutral Strong Buy Neutral Sell Buy
Trading
NIVF UNH ANTM CVS CI ELV
Last Close $0.3515 $320.52 $482.58 $78.41 $271.33 $330.91
High 52 $3.77 $610.79 $482.58 $83.04 $340.04 $452.91
Low 52 $0.12 $237.77 $482.58 $43.78 $244.41 $274.66
Price vs. 52 Week High -90.68 % -47.52 % 0 % -5.58 % -20.21 % -26.94 %
Price vs. 52 Week Low 192.92 % 34.8 % 0 % 79.1 % 11.01 % 20.48 %
Total Return
NIVF UNH ANTM CVS CI ELV
1 Month Return -71.42 % -10.12 % 0 % -4.98 % -9.34 % -5.12 %
3 Month Return -81.6 % 3.9 % 0 % 11.74 % -9.05 % 7 %
6 Month Return -88.08 % 9.8 % 0 % 25.4 % -15.46 % -17.95 %
9 Month Return -83.65 % -35.99 % 0 % 19.58 % -7.95 % -13.48 %
YTD Return -13.21 % -36.64 % 0 % 74.67 % -1.74 % -10.3 %
1 Year Return -38.21 % -44.45 % 0 % 40.6 % -15.87 % -16.06 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
NIVF UNH ANTM CVS CI ELV
Dividend Yield Percentage (TTM) - 3.2 % 2 % 3.51 % 2.1 % 2.1 %
Dividend Paid and Capex Coverage Ration (TTM) -2252.36 % 1.9 % 1.62 % 1.47 % 3.07 % 1.62 %
Dividend Per Share (TTM) - 8.73 % 6.84 % 2.66 % 6.04 % 6.84 %
Payout Ratio (TTM) - 97.22 % 27 % 191.74 % 26.84 % 27 %
Growth
NIVF UNH ANTM CVS CI ELV
Asset Growth -20.26 % 3.79 % 1.4 % 2.04 % 3.94 %
Gross Profit Growth 8.62 % -7.25 % -5.57 % 3.13 % -36.89 %
Revenue Growth 5.78 % 11.81 % 4.2 % 26.56 % 12.37 %
Revenue 3 Year -41.19 % 41.71 % 33.71 % 71.18 % 37.29 %
Revenue 5 Year -41.19 % 80.94 % 50.03 % 115.82 % 84.35 %
Revenue 10 Year -41.19 % 198.34 % 146.68 % 566.37 % 195.64 %
EBIT Growth -217.73 % -21.49 % -34.16 % 7.28 % -11.68 %
Net Income Growth -503.25 % -1.24 % -44.7 % -33.5 % -5.32 %
Net Income 3 Yeari Growth Per Share -43803.29 % -27.43 % -39.58 % -22.9 % 3.95 %
Net Income 5 Yeari Growth Per Share -43803.29 % -3.99 % -28.13 % -9.77 % 40.03 %
Net Income 10 Yeari Growth Per Share -43803.29 % 156.29 % -8.38 % 53.81 % 160.5 %
Operating Income Growth -2846.08 % -41.26 % -38.03 % 10.32 % -11.55 %
Operating Cash Flow Growth (CFG) -367.92 % 58.18 % -32.17 % -12.27 % -26.14 %
Operating 3 Year CFG -357.05 % 49.95 % -47.76 % 73.76 % -44.73 %
Operating 5 Year CFG -357.05 % 79.49 % -26.75 % 46.53 % -54.61 %
Operating 10 Year CFG -357.05 % 311.65 % 3.21 % 389.29 % 22.76 %
EPS Growth -279.38 % 0.13 % -43.61 % -30.28 % -2.44 %
EPS Diluted Growth -279.38 % 0.45 % -43.43 % -30.3 % -2.18 %
Book Value Per Share -120.35 % 1.2 % 0.86 % -5.75 % 11.58 %
Share Holder 3 Year Equity Growth Per Share 39.76 % 32.09 % 5.44 % 5.02 % 31.01 %
Share Holder 5 Year Equity Growth Per Share 39.76 % 58.88 % 22.26 % 21.38 % 49.46 %
Share Holder 10 Year Equity Growth Per Share 39.76 % 210.81 % 83.57 % 258.56 % 124.29 %
Dividend Per Share Growth - 87.43 % 9.92 % 14.46 % 6.45 %
Dividend 3 Year Growth Per Share - 136.93 % 34.62 % 40.89 % 34.62 %
Dividend 5 Year Growth Per Share - 213.64 % 33.9 % 13910.65 % 81.23 %
Dividend 10 Year Growth Per Share - 710.95 % 141.49 % 13311.7 % 174.27 %
Debt Growth 811.17 % 1.93 % 4.45 % 3.37 % 2.61 %
Free Cash Flow Growth -353.01 % 54.5 % -39.14 % -12.53 % -30.27 %
Updated On 31 Dec 2024 31 Dec 2025 31 Dec 2024 31 Dec 2024 31 Dec 2025
Profitability
NIVF UNH ANTM CVS CI ELV
Gross Profit Margin TTM 18.68 % 18.53 % 56.16 % 13.77 % 9.45 % 56.16 %
Return on Assets TTM 47.01 % 4.6 % 4.66 % 0.7 % 3.77 % 4.66 %
Return on Equity TTM 117.17 % 14.76 % 13.01 % 2.34 % 14.59 % 13.01 %
Return on Capital Employed TTM -10.61 % 9.74 % 5.75 % 2.83 % 9 % 8.69 %
Net Income Per EBT TTM 103.15 % 96.8 % 84.38 % 82.77 % 78.45 % 84.38 %
EBT Per Ebit TTM -449.94 % 77.5 % 95.98 % 45.84 % 83.17 % 95.98 %
EBIT Per Revenue TTM -140.89 % 4.24 % 3.52 % 1.16 % 3.32 % 3.52 %
Cash Flow To Debt Ratio TTM -115.45 % 48.84 % 13.39 % 11.39 % 25.45 % 13.39 %
Receivables Turnover TTM 1.02 19.44 - 10.11 8.67 9.22
Payables Turnover TTM 2.61 9.27 - 19.65 6.28 9.31
Inventory Turnover TTM 23.9 - - 18.01 44.21 -
Fixed Asset Turnover TTM 217.42 % - 4246.4 % 1433.09 % 7532.93 % 4246.4 %
Asset Turnover TTM 7.19 % 144.57 % 163.54 % 158.58 % 174.11 % 163.54 %
Operating Cash Flow Per Share TTM -55.81 42.07 19.34 7.17 32.58 19.34
Free Cash Flow Per Share TTM -55.83 35.15 14.31 4.96 27.96 14.31
Cash Per Share TTM 259.36 % 3090.22 % 4279.08 % 665.59 % 2597.5 % 4279.08 %
Operating Cash Flow Sales Ratio TTM -248.56 % 8.55 % 2.16 % 2.27 % 3.15 % 2.16 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.04 % 83.56 % 73.99 % 69.09 % 85.84 % 73.99 %
Cash Flow Coverage Ratios TTM -115.45 % 48.84 % 13.39 % 11.39 % 25.45 % 13.39 %
Price To Free Cash Flows Ratio TTM - 7.74 23.93 15.27 10.34 22.64
Price To Operating Cash Flows Ratio TTM -0.02 6.49 17.67 10.55 8.83 16.84
Price Cash Flow Ratio TTM -0.02 6.49 17.67 10.55 8.83 16.84
Income Statement (TTM)
NIVF UNH ANTM CVS CI ELV
Revenue $0.01B $447.57B $199.13B $402.07B $274.95B $199.13B
Gross Profit $0B $82.92B $177.95B $55.36B $25.99B $50.9B
Gross Profit Ratio 33.63% 18.53% 89.36% 13.77% 9.45% 25.56%
EBITDA $0B $23.06B $9.66B $9.86B $12.17B $9.66B
Net Income $-0B $14.23B $5.66B $1.77B $5.96B $5.66B
EPS Diluted -115.25 15.58 224.6 1.39 22.17 25.12
Balance Sheet (MRQ)
NIVF UNH ANTM CVS CI ELV
Long Term Debt $0B $72.32B $0B $89.05B $28.94B $30.8B
Total Liabilities $0.01B $207.88B $77.47B $178.16B $114.64B $77.47B
Total Equity $-0B $101.7B $44.03B $75.38B $41.24B $44.03B
Total Investments $0B $54.25B $0B $32.67B $15.79B $38.58B
Total Debt $0B $78.39B $1.25B $79.95B $31.97B $32.05B
Total Assets $0B $309.58B $121.49B $253.54B $155.88B $121.49B
Cash Flow Statement (TTM)
NIVF UNH ANTM CVS CI ELV
Net Income $-0B $25.4B $5.66B $1.77B $3.78B $5.66B
Inventory $0B $0B $0B $-1.27B $0B $0B
Dividends Paid $0B $-13.83B $-1.53B $-3.4B $-1.57B $-1.53B
Operating Cash Flow $-0.01B $38.29B $4.29B $10.64B $10.36B $4.29B
Capital Expenditure $-0B $-6.3B $-1.12B $-2.83B $-1.41B $-1.12B
Related Stocks
Ticker Name Price
ALHC Alignment Healthcare, Inc. 20.63
ANTM Anthem, Inc. 482.58
BHG Bright Health Group, Inc. 16.35
BMGL Basel Medical Group Ltd Ordinary Shares 0.6111
CABR Caring Brands, Inc. 0.8859
CI Cigna Corporation 287.81
CLOV Clover Health Investments, Corp. 2.12
CNC Centene Corporation 39.61
CVS CVS Health Corporation 75.7
ELV Elevance Health Inc. 325.64
GTS Triple-S Management Corporation 35.99
HUM Humana Inc. 181.3
MGLN Magellan Health, Inc. 94.99
MOH Molina Healthcare, Inc. 125.43
MRAI Marpai, Inc. 0.5899
OSCR Oscar Health, Inc. 12.88
UNH UnitedHealth Group Incorporated 273.22
Unlock